Objective To construct and identify the specific interference vector for second mitochondria- derived activator of caspase ( SMAC) gene in mice and perform lentiviral packaging. Methods According to the SMAC gene sequences in mice, three small interfering RNAs ( siRNAs) ( siRNA1, siRNA2, and siRNA3) and one negative control sequence ( siRNAn) were designed and synthesized, and mouse hepatocytes were transfected with the above siRNAs using Lipofectamine 2000. The inhibitory effects of these siRNAs on SMAC mRNA expression were evaluated by real- time PCR, and the optimal siRNA was screened out accordingly. Oligo DNA was synthesized based on the optimal siRNA and then connected to GV115 vector to obtain recombinant interference plasmid. The candidate clones were identified by PCR and sequenced. The recombinant interference plasmid, as well as pHelper 1. 0 and pHelper 2. 0, was used to transfect 293T cells for lentivirus packaging. Then, cell supernatants were collected and concentrated, and the lentiviral titer was determined by gradient dilution. Comparison between groups was made by analysis of variance, and multiple comparisons were made by SNK- q test. Results The three siRNAs had different inhibitory effects on SMAC mRNA expression in hepatocytes; siRNA1 showed the strongest inhibitory effect, with an inhibition efficiency of 70. 3%. Based on siRNA1, the oligo DNA was successfully synthesized and correctly connected to the lentiviral vector, as proved by sequencing. The lentiviral titer was 6 × 108TU / ml, as determined by gradient dilution. Conclusion The recombinant lentivirus that inhibits SMAC expression in mice has been constructed successfully, laying the foundation for further studies on the role of SMAC gene in liver failure.
[1]YAO WM, CHEN Y, XIE CS, et al.Clinical study on Xuebijing combined with Thymosinα1 in treatment of chronic liver failure[J].J Clin Exp Med, 2012, 11 (6) :421-423. (in Chinese) 姚维敏, 陈焰, 谢春生, 等.血必净注射液联合胸腺肽α1治疗慢性肝衰竭的疗效观察[J].临床和实验医学杂志, 2012, 11 (6) :421-423.
|
[2]LUO M, CAO WK.Research progress on microbial modulators in treatment of severe hepatitis with endotoxemia[J].J Clin Hepatol, 2011, 27 (7) :775-778. (in Chinese) 罗明, 曹武奎.微生态调节剂治疗重型肝炎内毒素血症的研究进展[J].临床肝胆病杂志, 2011, 27 (7) :775-778.
|
[3]SUN HY, LIU L, LU JF, et al.Potent bivalent smac mimetics:effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity[J].J Med Chem, 2011, 54 (9) :3306-3318.
|
[4]CHEN M, ZHOU J, LI H, et al.Effects of endotoxin on liver smac apoptosis channel[J].J Huazhong U Sci-Med, 2008, 28 (6) :660-664.
|
[5]DU CY, FANG M, LI YC, et al.Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition[J].Cell, 2000, 102 (1) :33-42.
|
[6]EMEAGI PU, THIELEMANS K, BRECKPOT K.The role of SMAC mimetics in regulation of tumor cell death and immunity[J].Immunology, 2012, 1 (6) :965-967.
|
[7]GIAGKOUSIKLIDIS S, VOGLER M, WESTHOFF MA, et al.Sensitization for gamma-irradiation-induced apoptosis by second mitochondria-derived activator of caspase[J].Cancer Res, 2005, 65:10502-10513.
|
[8]KRAMER O, KLAISING S, NOLL T.Methods in mammalian cell line engineering:from random mutagenesis to sequence-specific approaches[J].Appl Microbiol Biot, 2010, 88 (2) :425-436.
|
[9]RAMACHANDRAN PV, IGNACIMUTHU S.RNA interference-a silent but an efficient therapeutic tool[J].Appl Microbiol Biot, 2013, 169 (6) :1774-1789.
|
[10]TAKAMURA K, TSUCHIDA K, MIYAKE H, et al.Activin and activin receptor expression changes in liver regeneration in rat[J].J Surg Res, 2005, 126 (1) :3-11.
|
[11]GRASSMANN R, JEANQ KT.The roles of microRNAs in mammalian virus infection[J].Biochim Biophys Acta, 2008, 1779 (11) :706-711.
|
[12]LEI M, JIAO HW, LIU T, et al.siRNA targeting mCD14 inhibits TNF-alpha, MIP-2, and IL-6 secretion and NO production from LPS-induced RAW264.7 cells[J].Appl Microbiol Biot, 2011, 92 (1) :115-124.
|
[13]RUBINSON DA, DILLON CP, KWIATKOWSKI AV, et al.A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference[J].Nature Genet, 2003, 33 (3) :401-406.
|
[14]ZHANG SM, XIE YM, HAO CQ, et al.Construction of the RNA interference vector of tissue inhibitor of matrix metalloproteinase-1gene and its inhibitory effects[J].J Clin Hepatol, 2012, 28 (2) :135-138. (in Chinese) 张素梅, 谢玉梅, 郝春秋, 等.基质金属蛋白酶抑制剂-1基因的RNA干扰载体构建及其抑制效应[J].临床肝胆病杂志, 2012, 28 (2) :135-138.
|
[1] | Xiaoyong DUO, Shijie ZHANG, Hongwei ZHANG, Jing YANG, Wenqiang WANG, Linzhi YU, Baocai ZHANG, Yicheng ZHUO, Yunchao JIA, Yan PENG, Shuai HU. Association between gallstones and metabolic syndrome in southern Xinjiang, China[J]. Journal of Clinical Hepatology, 2022, 38(8): 1859-1864. doi: 10.3969/j.issn.1001-5256.2022.08.026 |
[2] | Aipire ALIYEGULI, Maimaitiyusufu PIERDIWASI, Jian WANG, Aili AIKEBAIER, Abudureyimu KELIMU. Effects of FGB gene polymorphism on fibrinogen level and gallstones incidence in Xinjiang, China[J]. Journal of Clinical Hepatology, 2021, 37(9): 2171-2176. doi: 10.3969/j.issn.1001-5256.2021.09.032 |
[3] | Peng Lu:Cheng, Shao ZhangFeng, Chen JiaQin, Chen Wei. Effect of aerobic exercise combined with silybin on intestinal mucosal barrier in mice with obstructive jaundice[J]. Journal of Clinical Hepatology, 2020, 36(7): 1577-1583. doi: 10.3969/j.issn.1001-5256.2020.07.025 |
[4] | Li ChangXu, Yuan JingJing, Wang ShouQian, Xu LuYao, Wang YingChao. Perioperative coagulation factor Ⅷ replacement therapy for patients with gallbladder stones and hemophilia A: A report of three cases[J]. Journal of Clinical Hepatology, 2020, 36(9): 2075-2076. doi: 10.3969/j.issn.1001-5256.2020.09.036 |
[5] | Zhu PeiYao, Yang Jun, Yang Yong, Han YaDong, Zhuang Lei, Han Yong. Necessity of magnetic resonance cholangiopancreatography in patients with initial diagnosis of gallstones on color Doppler ultrasound and an analysis of related indications[J]. Journal of Clinical Hepatology, 2019, 35(6): 1293-1298. doi: 10.3969/j.issn.1001-5256.2019.06.022 |
[6] | Hong Cen, Han JuQiang, Qi XingShun. An excerpt of AGA clinical practice update: Coagulation in cirrhosis (2019)[J]. Journal of Clinical Hepatology, 2019, 35(10): 2191-2191. doi: 10.3969/j.issn.1001-5256.2019.10.011 |
[7] | Xiong Zhuang, Liu YangYang, Huo ShaoKai, Gong JiaLian, Jin TianYi, Wang Qiang, Wang HuiLin, Liu TieJun, Leng Yan. Research advances in vitamin K1 in treatment of coagulopathy of liver failure[J]. Journal of Clinical Hepatology, 2019, 35(9): 2099-2103. doi: 10.3969/j.issn.1001-5256.2019.09.048 |
[8] | Li HongHong, Zhao Ge, Xue JunJun, Ning YaWen, Guo HongYi, Li WenLong, Guo ChunLei. A case of double gallbladder malformation with obstructive jaundice[J]. Journal of Clinical Hepatology, 2018, 34(7): 1535-1537. doi: 10.3969/j.issn.1001-5256.2018.07.036 |
[9] | Wang XianPeng, Meng XianZhi. Risk factors for gallstones complicated by acute biliary pancreatitis[J]. Journal of Clinical Hepatology, 2018, 34(8): 1728-1732. doi: 10.3969/j.issn.1001-5256.2018.08.027 |
[10] | Wang Bin, Luo Xiao, Sun BaoZhen, Yang Guang, Meng ZiHui, Ji DeGang. Laparoscopic cholecystectomy for cold agglutinin syndrome with gallstones: a case report[J]. Journal of Clinical Hepatology, 2017, 33(4): 740-741. doi: 10.3969/j.issn.1001-5256.2017.04.032 |
[11] | Wang Qiang, Zhang XianYong, Yan XiaoLin. Association of blood lipid levels with the risk of cholecystectomy and postoperative pain[J]. Journal of Clinical Hepatology, 2017, 33(10): 1961-1965. doi: 10.3969/j.issn.1001-5256.2017.10.022 |
[12] | Zhou BingBing, Wang XueMei, Zhang Qian, Xu ShiYi, Dan ZhongYan, Lai YaXin, Wang HaoYu. Association between metabolic syndrome and gallstones[J]. Journal of Clinical Hepatology, 2017, 33(5): 880-882. doi: 10.3969/j.issn.1001-5256.2017.05.017 |
[13] | Li Jing, Wu GuangLi, Wang Wei, Xiao Xin, Liu HuiNa, Qu DongDong, Cai YiWei. Analysis of pathogenic bacteria in bile and blood of patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2017, 33(2): 320-323. doi: 10.3969/j.issn.1001-5256.2017.02.025 |
[14] | Li Juan, Wei XiaoGuo, Lu QiMing, Zhan Li, Liu PengCheng. Research advances in association between diseases outside the gallbladder and gallstones[J]. Journal of Clinical Hepatology, 2016, 32(5): 1018-1021. doi: 10.3969/j.issn.1001-5256.2016.05.050 |
[15] | Li ZhangZheng, Liu QuanDa, Yu HuiJie, Hu WenWei, Li Xue, Liu MingHao. Correlation between serum levels of complement C5a and liver fibrosis markers in patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2016, 32(3): 495-498. doi: 10.3969/j.issn.1001-5256.2016.03.020 |
[16] | Pan YaJun, Sun ShaoFu. Predictive value of serum CA19-9 in predicting acute cholangitis in patients with obstructive jaundice[J]. Journal of Clinical Hepatology, 2016, 32(8): 1553-1556. doi: 10.3969/j.issn.1001-5256.2016.08.024 |
[17] | Lin QianHuang, Xu Hui, Tang XiaoLong, Ding Zheng, Tang WenJun, Wu KaiKai, Xun JinLiang. A case of gallstones with gallbladder-stomach fistula and biliary ileus[J]. Journal of Clinical Hepatology, 2016, 32(11): 2177-2178. doi: 10.3969/j.issn.1001-5256.2016.11.039 |
[18] | Dai ShuLong, Yang ShiYong, Yang KunXing. Systemic sclerosis with gallbladder stone disease: a report of one case[J]. Journal of Clinical Hepatology, 2015, 31(6): 963-964. doi: 10.3969/j.issn.1001-5256.2015.06.033 |
[19] | Zhang Peng, Yu CongHui. Clinical analysis of relationship between gallstone morphology and biliary pancreatitis[J]. Journal of Clinical Hepatology, 2014, 30(1): 46-49. doi: 10.3969/j.issn.1001-5256.2014.01.015 |
[20] | Wang TianRan, Wang LanTian, Qu YuanQing, Gu Yu, Zou ZiYing, Chen Li. Comparative analysis of serum markers of cardiac function in a rabbit model of and human patients with obstructive jaundice [J]. Journal of Clinical Hepatology, 2013, 29(3): 227-229. |